SI3611158T1 - Derivat 1,3-di-okso-indena, farmacevtsko sprejemljiva sol ali optični izomer le-tega, postopek priprave le-tega in farmacevtski sestavek, ki ga vsebuje kot protivirusno učinkovino - Google Patents

Derivat 1,3-di-okso-indena, farmacevtsko sprejemljiva sol ali optični izomer le-tega, postopek priprave le-tega in farmacevtski sestavek, ki ga vsebuje kot protivirusno učinkovino

Info

Publication number
SI3611158T1
SI3611158T1 SI201232059T SI201232059T SI3611158T1 SI 3611158 T1 SI3611158 T1 SI 3611158T1 SI 201232059 T SI201232059 T SI 201232059T SI 201232059 T SI201232059 T SI 201232059T SI 3611158 T1 SI3611158 T1 SI 3611158T1
Authority
SI
Slovenia
Prior art keywords
antiviral
oxo
preparation
pharmaceutically acceptable
pharmaceutical composition
Prior art date
Application number
SI201232059T
Other languages
English (en)
Inventor
Young Sik Jung
Chong Kgo Lee
Ihl Young Choi
Hae Soo Kim
Pil Ho Kim
Soo Bong Han
Johan Neyts
Hendrik Jan Thibaut
Original Assignee
Korea Research Institute Of Chemical Technology
Katholieke Universiteit Leuven K. U. Leuven R&D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Research Institute Of Chemical Technology, Katholieke Universiteit Leuven K. U. Leuven R&D filed Critical Korea Research Institute Of Chemical Technology
Priority claimed from EP19179546.7A external-priority patent/EP3611158B1/en
Publication of SI3611158T1 publication Critical patent/SI3611158T1/sl

Links

SI201232059T 2011-06-16 2012-06-18 Derivat 1,3-di-okso-indena, farmacevtsko sprejemljiva sol ali optični izomer le-tega, postopek priprave le-tega in farmacevtski sestavek, ki ga vsebuje kot protivirusno učinkovino SI3611158T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20110058704 2011-06-16
EP19179546.7A EP3611158B1 (en) 2011-06-16 2012-06-18 1,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient

Publications (1)

Publication Number Publication Date
SI3611158T1 true SI3611158T1 (sl) 2024-07-31

Family

ID=90469768

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201232059T SI3611158T1 (sl) 2011-06-16 2012-06-18 Derivat 1,3-di-okso-indena, farmacevtsko sprejemljiva sol ali optični izomer le-tega, postopek priprave le-tega in farmacevtski sestavek, ki ga vsebuje kot protivirusno učinkovino

Country Status (4)

Country Link
ES (1) ES2974025T3 (sl)
PL (1) PL3611158T3 (sl)
PT (1) PT3611158T (sl)
SI (1) SI3611158T1 (sl)

Also Published As

Publication number Publication date
PL3611158T3 (pl) 2024-07-29
PT3611158T (pt) 2024-03-22
ES2974025T3 (es) 2024-06-25

Similar Documents

Publication Publication Date Title
EP2522653A4 (en) BIGUANIDE DERIVATIVE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE BIGUANIDE DERIVATIVE AS AN ACTIVE SUBSTANCE
EP2917180A4 (en) GPR40 RECEPTOR AGONIST, METHODS OF PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE SUBSTANCE
WO2013100566A8 (en) Phenyl alkyl carbamate derivative compound and pharmaceutical composition containing the same
EP2657231A4 (en) SUBSTITUTED AZOLES, ANTIVIRAL ACTIVE INGREDIENT, PHARMACEUTICAL COMPOSITION AND PROCESS FOR PREPARING AND USING SAME
WO2012021715A3 (en) Stable formulations of linaclotide
EP3312175A4 (en) Heteroaryl derivative or pharmaceutically acceptable salt thereof, preparation method therefor, and pharmaceutical composition for preventing or treating diseases associated with pi3 kinases, containing same as active ingredient
HK1181389A1 (en) Pharmaceutical composition comprising amide derivative or pharmaceutically acceptable salt thereof
EP2722042A4 (en) INDANONE DERIVATIVES, THEIR OPTICAL ISOMERS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING VIRAL DISEASES
ZA201500362B (en) Novel compound having ability to inhibit 11b-hsd1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient
IL230487B (en) 6-(n-(7-chloro-1-hydroxy-3,1-dihydrobenzo[c][1,2]oxaborole-5-yl)methylsulfonamido)-5-cyclopropyl-2-(4-fluorophenyl)-n- Methylbenzofuran-3-carboxamide, their salts and pharmaceutical preparations containing them
EP2796450A4 (en) 6-AMINOPYRIDINE-3-OL DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, AND PHARMACEUTICAL COMPOSITION CONTAINING THESE DERIVATIVES OR THESE SALTS AS ACTIVE INGREDIENTS FOR THE PREVENTION OR TREATMENT OF ANGIOGENESIS DISEASES
EP2987786A4 (en) AMIDOPYRIDINOL DERIVATIVE OR PHARMACEUTICAL, SALT AND PHARMACEUTICAL COMPOSITION THEREFOR AS ACTIVE SUBSTANCE
PL2647637T3 (pl) Pochodna purynylopirydynyloamino-2,4-dlfluorofenylo-sulfonamidu, jej farmaceutycznie dopuszczalna sól, sposób jej wytwarzania oraz zawierająca ją jako składnik aktywny kompozycja farmaceutyczna o aktywności hamującej kinazę Raf
WO2013169746A3 (en) N-ethyl-4-hydroxyl-1-methyl-5- (methyl(2,3,4,5,6-pentahydroxyhexyl) amino) -2-oxo-n-phenyl-1,2-dihydroquinoline-3-carboxamide
EP2871187A4 (en) NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENT
SI2722322T1 (sl) 1,3-di-okso-indenski derivat, farmacevtsko sprejemljiva sol ali optični izomer le-tega, postopek njegov priprave in farmacevtski sestavek, ki ga vsebuje kot protivirusno aktivno sestavino
EP2799082A4 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORAL DISEASES OR ASTHMA CONTAINING A STOREM STEREMIA OVALIFOLIA EXTRACT OR A FRACTION OF IT AS AN ACTIVE SUBSTANCE
HK1216253A1 (zh) 新型化合物、其藥學上可接受的鹽或光學異構體、用於製備它們的方法以及包含它們作為有效成分的用於預防或治療病毒性疾病的藥物組合物
EP3404020A4 (en) PYRIDINOL DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT
EP2636677A4 (en) CDK-HEMMENDES PYRROLOPYRIMIDINONCARBOXAMID DERIVATIVE OR PHARMACEUTICAL ACCEPTABLE SALT AND THE PHARMACEUTICAL COMPOSITION CONTAINING THEREOF FOR THE PREVENTION OR TREATMENT OF LIVER CELL CARCINOMA
IL230907A0 (en) Salt and formations of a pyrazolopyrimidine compound, a medical composition that includes the above, and a preparation and use process for them
EP2862573A4 (en) COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF VASER SPERMABILITY-RELATED DISEASES WITH IMATINIB OR PHARMACEUTICAL ACCEPTABLE SALT AS AN ACTIVE SUBSTANCE
EP2842938A4 (en) NOVEL BETA-ALANINE DERIVATIVES, THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME AS ACTIVE INGREDIENT
PT3611158T (pt) Derivado de 1,3-di-oxo-indeno, seu sal farmaceuticamente aceitável ou isómero ótico, seu método de preparação, e composição farmacêutica contendo o mesmo como ingrediente ativo, antiviral
ZA201803722B (en) Pharmaceutical composition containing, as active ingredient, 7-azaindolin-2-one derivative or pharmaceutically acceptable salt thereof